Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy.
Explore this paper's citation graph
Summary
It is confirmed that post-menopausal women in the overall population respond differently to estrogen-only treatment compared with estrogen-progestin treatment, due to different hormone regimens and/or increased cardiovascular disease in hysterectomized women.
- Type
- article
- Published
- 2007-06-01
- Cited by
- 47
- References
- 34
- Access
- Open access
- OpenAlex
- https://openalex.org/W1995260041
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:14967220
Keywords
Estrogen, Estrogen replacement therapy, Progestin, Medicine, Estrogen therapy
References
- Can Hysterectomy Be Considered a Risk Factor for Cardiovascular Disease?
- Early menopause and the risk of myocardial infarction.
- Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
- Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
- A simulation using data from a primary care practice database closely replicated the women's health initiative trial.
- Breast cancer and hormone-replacement therapy in the Million Women Study.
- The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants.
- Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
- Reducing Bias in Observational Studies Using Subclassification on the Propensity Score
- Effect of Hormone Replacement Therapy on Lipoprotein(a) and Lipid Levels in Postmenopausal Women: Influence of Various Progestogens and Duration of Therapy
- Estimating and Using Propensity Scores with Partially Missing Data
- Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
- Estrogen carcinogenesis in breast cancer.
- Breast Cancer Risk in Postmenopausal Women Using Estrogen-Only Therapy
- Breast cancer and hormone-replacement therapy: the Million Women Study.
- The UK General Practice Research Database.
- Simulation of the Syst-Eur randomized control trial using a primary care electronic medical record was feasible.
- Total Abdominal Hysterectomy May Be a Risk Factor for Acute Myocardial Infarction in Postmenopausal Women: An Age-Matched, Case-Controlled Retrospective Analysis
- Usefulness of prior hysterectomy as an independent predictor of Framingham risk score (The Women's Health Initiative).
- Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
Cited by
- Monitoring of patients for the development of adverse reactions to antihypertensive drugs in general practice
- Prior event rate ratio adjustment: numerical studies of a statistical method to address unrecognized confounding in observational studies
- Effect of bacterial vaginosis, Lactobacillus and Premarin estrogen replacement therapy on vaginal gene expression changes.
- Estrogen and colorectal cancer incidence and mortality
- Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
- Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women
- Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings
- Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats.
- Colorectal Cancer Incidence and Postmenopausal Hormone Use by Type, Recency, and Duration in Cancer Prevention Study II
- Estrogen plus progestin and colorectal cancer incidence and mortality.
- Estrone and progesterone inhibit the growth of murine MC38 colon cancer line.
- Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition
- Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: A debated clinical issue
- The effect of estrogen vs. combined estrogen‐progestogen therapy on the risk of colorectal cancer
- Clinical experiences with drospirenone: from reproductive to postmenopausal years.
- Primary Prevention of Colorectal Cancer
- Effects of genistein in combination with conjugated estrogens on endometrial hyperplasia and metabolic dysfunction in ovariectomized mice.
- Randomization and Rules for Causal Inferences in Biology: When the Biological Emperor (Significance Testing) Has No Clothes
- The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention.
- Cardiovascular health in the menopausal woman: impact of the timing of hormone replacement therapy
Related papers
- Hormone replacement therapy: post‐menopausal sex life and attitudes towards sex
- Alternatives to hormone replacement therapy: a multi-method study of women's experiences.
- [Actual experiences of menopause in 342 women].
- Women's perceptions of the effects of menopause and hormone replacement therapy on skin
- An epidemiological study on knowledge, attitude and practice of married women about menopause and hormone replacement therapy
- Hormone replacement before menopause. Is it a good idea?
- "HRT is for women who go mad at the menopause".
- Estrogen replacement therapy (ERT) and hormone replacement therapy (HRT) in the prevention of cardiovascular diseases.